Our Custom dsRNA Synthesis service supports biotechnology companies, agricultural research teams, CROs, and academic groups that need sequence-defined double-stranded RNA for RNA interference studies, target validation, assay development, and long dsRNA screening workflows. Double-stranded RNA projects often look simple at the concept stage, but experimental success depends on much more than ordering a target sequence. Target-region choice, DNA template architecture, transcription route, duplex formation, purification depth, and application-fit QC all influence whether the final dsRNA performs consistently in cell, organism, greenhouse, or biochemical workflows.
We provide an integrated service covering target review, template design, custom DNA preparation, in vitro transcription planning, sense/antisense RNA generation, duplex annealing, purification, analytical characterization, and scale-up support. By combining workflow-aware RNA design with practical manufacturing and QC planning, our team helps clients move from a project idea to research-ready dsRNA materials with clearer specifications, lower development risk, and documentation that supports internal decision-making.
Target Region Selection and Off-Target Control: Long dsRNA can generate misleading results when the selected fragment overlaps homologous transcripts, conserved domains, repetitive regions, or unintended species sequences. We help clients review target regions against project biology, sequence complexity, and off-target risk so that the dsRNA trigger is better aligned with the intended RNAi outcome.
Template Architecture and Transcription Feasibility: dsRNA performance starts with the template strategy. Promoter placement, amplicon quality, GC-rich segments, secondary-structure-prone regions, and target length all affect transcription behavior and downstream duplex quality. Our team builds fit-for-purpose template plans that can incorporate custom DNA synthesis, PCR-ready designs, or dual-transcription workflows depending on the project.
Duplex Integrity, Annealing Quality, and Residual Single-Strand Risk: Many failed dsRNA studies trace back to incomplete annealing, truncated strands, or residual ssRNA and template contaminants. We structure production and cleanup steps to improve duplex completeness and provide project-relevant analytical review through our oligo analysis and purification capabilities.
RNase Exposure, Handling Format, and Scale Transition: Researchers often need to move from feasibility batches to larger quantities for repeat assays, feeding studies, spray evaluation, or formulation screening. We support planning around concentration, buffer, normalization, lyophilized versus solution delivery, and scalable manufacturing routes, including linkage with large-scale RNA oligonucleotide synthesis workflows when broader output is required.
Application-Fit Delivery and Downstream Use: The right dsRNA for soaking, feeding, microinjection, transfection, or surface-application research is not always defined by sequence alone. We help clients match dsRNA format, length strategy, labeling options, and optional formulation considerations with the intended study design, and can extend support through our drug delivery platform for projects that require additional carrier evaluation.
Our service platform is built for clients who need more than a simple transcription reaction. We support the technical decisions that determine whether a dsRNA construct is easy to manufacture, analytically interpretable, and usable in the downstream assay or organism model.
Depending on project scope, we can support single targets, comparative target panels, labeled constructs, long dsRNA programs, and scale-up campaigns intended for repeated screening or nonclinical field-oriented evaluation.
This table helps clients define what can be customized in a dsRNA project before production begins, including target input, template route, output format, and optional analytical requirements. It is especially useful for early-stage inquiry alignment and project scoping.
| Project Dimension | What We Can Support | Typical Client Inputs | Why It Matters |
| Target Information | Project design can start from a gene name, transcript ID, accession number, target sequence, or client-defined fragment. | Gene or transcript reference, FASTA sequence, organism information, target region preference. | Clear target definition improves sequence selection, reduces redesign, and supports more efficient project kickoff. |
| dsRNA Length Strategy | Support for short defined duplexes, medium-length dsRNA, and long dsRNA constructs for RNAi research. | Desired construct type, target region length, application scenario, downstream assay format. | Length affects transcription route, purification burden, analytical approach, and application fit. |
| Template Preparation Route | Synthetic DNA template design, PCR-derived template preparation, plasmid-based template workflows, or client-supplied DNA. | Available template material, promoter preference, sequence constraints, internal cloning status. | Template strategy influences transcription reliability, batch reproducibility, and overall project timing. |
| Production Workflow | Separate sense and antisense strand production, duplex annealing workflows, or long-RNA-oriented IVT strategies. | Preferred manufacturing logic, required scale, labeling needs, construct complexity. | Different workflows suit different sequence lengths, output goals, and QC expectations. |
| Purification Level | Standard cleanup, enhanced purification, impurity-focused cleanup, and application-fit release preparation. | Assay sensitivity, acceptable impurity level, repeat-use requirements, internal QC expectations. | Purification depth can directly affect duplex usability, reproducibility, and downstream troubleshooting burden. |
| Optional Modifications | Support for labeled, tagged, or workflow-adapted dsRNA constructs when project design requires additional functionality. | Fluorescent tracking need, affinity tag requirement, uptake study plan, assay-specific formatting request. | Additional functionality must be planned carefully to preserve duplex quality and downstream performance. |
| Delivery Format | Lyophilized material, solution delivery, normalized concentration, aliquoted batches, or bulk research output. | Storage plan, shipping preference, internal workflow setup, repeat-use expectations. | The final format affects handling convenience, stability planning, and assay consistency. |
| QC and Documentation Scope | Fit-for-purpose analytical review and structured reporting aligned with project goals. | Identity check needs, integrity review depth, batch release expectations, documentation format preference. | Clear QC scope helps clients understand exactly what will be delivered and how it supports decision-making. |
Different dsRNA formats are not interchangeable in practice. This table helps clients compare common length strategies based on research objective, workflow advantages, and technical considerations before selecting a production route.
| dsRNA Format | Typical Research Use | Key Advantages | Main Technical Considerations |
| Short Defined dsRNA Duplex | Mechanistic studies, assay controls, defined trigger evaluation, and projects requiring tightly specified duplex material. | Higher construct definition, easier comparison across batches, and simpler integration into structured assay workflows. | May require more careful design when broader RNAi coverage or larger-fragment targeting is preferred. |
| Medium-Length dsRNA | Target validation, comparative screening, and projects balancing sequence coverage with manageable production complexity. | Useful middle-ground option for clients who need broader target coverage without moving immediately to very long constructs. | Template design, transcription behavior, and purification planning should still be aligned with sequence complexity. |
| Long dsRNA | RNAi screening, agricultural RNAi research, feeding studies, and broader trigger evaluation workflows. | Provides wider target-fragment coverage and is often preferred where long dsRNA is the practical research format. | Requires stronger control of template quality, transcription consistency, duplex integrity, and cleanup strategy. |
| Labeled or Functionalized dsRNA | Uptake studies, tracking experiments, assay development, and capture-enabled workflows. | Adds traceability or workflow functionality beyond basic gene-silencing use. | Label placement and modification strategy must be selected to avoid compromising duplex behavior. |
| Normalized Research Batches | Repeat assays, multi-condition studies, comparative screening campaigns, and distributed team workflows. | Improves operational consistency and reduces manual setup variation across experiments. | Requires concentration control, batch formatting, and clear final delivery specifications. |
| Bulk dsRNA Output | Larger research campaigns, repeated nonclinical evaluation, and programs moving beyond feasibility-stage quantities. | Supports scale transition and reduces the need for repeated small-batch redevelopment. | Scale-up planning should account for route selection, purification burden, and batch-to-batch consistency. |
Clients evaluating custom dsRNA synthesis services usually want to know not only what can be made, but also how the final material is checked before delivery. This table presents the most decision-relevant QC categories in a client-friendly format.
| QC Item | What It Helps Confirm | When It Is Especially Important | Typical Deliverable |
| Identity Confirmation | Confirms that the produced dsRNA corresponds to the intended project design and target sequence plan. | Important for all projects, especially when multiple targets, templates, or screening constructs are involved. | Batch-specific identity review or project-linked production record. |
| Size and Integrity Assessment | Shows whether the dsRNA is consistent with the expected construct length and whether degradation or truncation is evident. | Especially important for long dsRNA, scale-up batches, and studies sensitive to construct integrity. | Integrity-oriented analytical result or electrophoretic size review. |
| Duplex Completeness Review | Helps assess whether strand annealing is sufficiently complete and whether residual single-stranded material may remain. | Critical when the project depends on well-formed duplex material rather than mixed RNA populations. | Duplex-quality assessment or annealing-related QC summary. |
| Residual Template or Process Impurity Review | Provides confidence that unwanted DNA template, enzymes, free nucleotides, or reaction carryover have been addressed. | Important for sensitive assays, repeat-use material, and higher-output batches. | Cleanup-oriented QC note or impurity-focused release information. |
| Concentration Determination | Confirms usable batch concentration and supports more reliable downstream dosing or normalization. | Useful for nearly all projects and especially important when comparative studies or repeat assays are planned. | Concentration result, fill-volume information, or normalized batch specification. |
| Batch Formatting Check | Ensures the material is prepared in the agreed delivery format, such as aliquots, solution, or lyophilized presentation. | Important when material will be shared across teams, stored long term, or used in staged experiments. | Final delivery specification with packaging and format details. |
| Label or Functional Tag Confirmation | Supports confidence in labeled or assay-adapted dsRNA constructs used for tracking, capture, or workflow-specific applications. | Important only when the project includes fluorophores, affinity tags, or other added functionality. | Modification-aware analytical summary or construct-specific QC record. |
| Project Documentation Package | Brings together the agreed batch information in a format useful for internal review, procurement records, and follow-on planning. | Especially valuable for outsourced projects, multi-step programs, and repeat-order expansion. | Structured reporting package aligned with the agreed service scope. |
Our workflow is designed to reduce ambiguity before production starts and to give clients a clearer path from target concept to research-ready dsRNA delivery.
We review the target organism or system, gene or transcript information, intended use, preferred quantity, and required delivery format. This step clarifies whether the project is best served by a defined dsRNA construct, a long dsRNA workflow, or a broader RNA production route.
Candidate regions are assessed for target relevance, specificity, sequence complexity, and practical manufacturability. Where needed, we compare multiple fragments to reduce off-target risk and improve downstream interpretability.
We define the DNA template route, promoter configuration, strand-generation logic, and any labeling or modification needs. This stage establishes the production plan and avoids preventable changes after execution begins.
The selected production route is executed through IVT, separate strand preparation, and controlled duplex formation as appropriate for the construct type. Process steps are aligned with length, scale, and downstream purity requirements.
Cleanup steps are used to remove reaction carryover and improve usability of the final dsRNA material. Intermediate review helps identify integrity or annealing issues before material is finalized for release.
We complete the agreed QC package, normalize the batch where required, and prepare the final material in a format appropriate for storage, shipping, and downstream use. This may include aliquoting, lyophilization, or solution delivery.
Clients receive the agreed deliverables together with structured project documentation that supports assay setup, internal review, or progression to a larger follow-on order. We remain available for sequence refinement or scale-up planning based on first-round data.
Custom dsRNA programs are often delayed by fragmented vendors, underdefined QC expectations, or sequence choices that are not aligned with the final biological workflow. Our service model is designed to solve those practical issues before they become expensive experimental problems.
We support dsRNA programs across research settings where sequence-specific silencing, long-RNA production, and application-fit delivery matter. The examples below reflect common directions requested by biotechnology, agbio, and discovery teams.
dsRNA consists of two complementary RNA strands, while ssRNA contains only one strand. dsRNA is key for RNA interference (RNAi) and gene silencing, while ssRNA is primarily involved in mRNA processes.
dsRNA is used for RNAi-based gene silencing, plant protection, and crop improvement. It also plays a significant role in diagnostic applications and viral model systems.
BOC Sciences uses RNA polymerase for in vitro synthesis of dsRNA, providing custom sequences and lengths. Our synthesis process is highly controlled to ensure high purity and sequence accuracy.
We offer a wide range of modifications for dsRNA, including phosphorothioates, spacers, biotin labeling, and fluorophores. These modifications enhance stability and functionality for various research needs.
Each batch of dsRNA is verified using mass spectrometry and undergoes strict quality control for purity and sequence accuracy. We provide Certificates of Analysis (COA) and QC reports for all synthesized products.
Turnaround times for dsRNA synthesis typically range from a few days to a few weeks, depending on the complexity of the project. We also offer expedited services to meet urgent research needs.
Whether you need a single dsRNA construct for target validation, a comparative panel for RNAi screening, a labeled duplex for uptake work, or a broader long dsRNA program for agbio research, our team can help you define the right sequence, production route, QC scope, and delivery format before work begins. We support clients from early feasibility through repeat-batch and scale-up planning, with coordinated access to related DNA, RNA, purification, and characterization capabilities. Contact us to discuss your custom dsRNA synthesis requirements and build a project plan that fits your research workflow.
